Susceptibilities of Bordetella pertussis strains to antimicrobial peptides.

AUTOR(ES)

Fernandez, R C

RESUMO

We examined the susceptibilities of Bordetella pertussis strains to several antimicrobial peptides by determining the concentration required to inhibit or kill 50% of the bacterial population. The peptides are ranked in decreasing potency as follows: cecropin B > cecropin A >> melittin > cecropin P1 > (ala8,13,18)-magainin II amide > mastoparan = defensin HNP1 > protamine > or = magainin II = magainin I. By using a radial diffusion assay to compare susceptibilities between strains, wild-type B. pertussis BP338 was more resistant than the avirulent bvg mutant strain BP347 and the brk mutant strain BPM2041 to killing by cecropin P1. In contrast, compared with the wild type, the avirulent BP347 strain was highly resistant to killing by protamine and defensin HNP1.

Documentos Relacionados

• Antimicrobial Susceptibility of Bordetella pertussis Strains Isolated from 1960 to 1981
• Antimicrobial susceptibilities of Bordetella species isolated in a Multicenter Pertussis Surveillance Project.
• In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to seven fluoroquinolones.
• In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to six new oral cephalosporins.
• In Vitro Susceptibilities of Bordetella pertussis and Bordetella parapertussis to BAY 12-8039, Trovafloxacin, and Ciprofloxacin